Retina Labs
Retina Labs is a cloud-based teleophthalmology company that provides diabetic eye disease screening and in-home preventive screenings to U.S. health plans and to primary care practices, ACOs, and health systems, using its iVision platform, ComplyHub platform, and proprietary portable fundus camera.
- Company typePrivate
- Founded2009
- HeadquartersMontréal, Canada
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Retina Labs does
Retina Labs is a private, cloud-based teleophthalmology company that provides diabetic eye disease screening and preventive care services to U.S. health plans and to primary care practices, ACOs, and health systems. Its core offering combines a proprietary portable non-mydriatic fundus camera with the iVision teleophthalmology platform — retinal image capture, cloud-based software workflow, and remote interpretation by board-certified ophthalmologists — sold under three service lines: point-of-care teleretinal screening for providers, in-home diabetic eye exams and broader preventive screenings delivered by field technologists, and direct-to-member at-home lab test kits (HbA1c, KED, colorectal cancer). The ComplyHub platform (launched 2020) underpins in-home program delivery and now includes a Member Experience Survey Dashboard. Founded in 2009 (per company timeline) and headquartered at 555 Marriott Drive, Suite 315, Nashville, TN, the company is led by President & CEO and investor Richard Pridham (joined June 2016) and co-founder/CTO Hamid Fotuhi, with a Clinical Director (Dr. Cyrus Golshani, MD) overseeing ophthalmologist interpretation.
The business is anchored in two enterprise GTM motions: a payer-centric HEDIS/Star Rating motion targeting Medicaid and Medicare Advantage health plans with managed-service contracts to close quality gaps, and a point-of-care motion enabling primary care providers to integrate diabetic eye exams into routine care for reimbursement revenue. The company generates revenue through managed services contracts for in-home screening programs, subscription/recurring revenue for point-of-care teleretinal screening deployments, and managed services for at-home lab test kit fulfillment and member outreach. Named enterprise customers include Wellpoint West Virginia (150,000+ Medicaid/CHIP members), Sentara Health Plans, The Health Plan of West Virginia, VIVA MEDICARE, Highmark, and Independence, alongside provider-side deployments with Ontario Telemedicine Network, Maisonneuve Rosemont Hospital, RUIS McGill, First Nations of Quebec and Labrador, and Access Family Health. The company reports 98% patient satisfaction, NPS of 95, and documented outcomes of 10,000+ HEDIS gaps closed (Sentara) and 1,800+ gaps closed (Health Plan of West Virginia).
Retina Labs firmographics
Firmographics- Name
- Retina Labs
- Legal name
- Retina Labs USA Inc.
- Website
- https://retina-labs.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Retina Labs is a cloud-based teleophthalmology company that provides diabetic eye disease screening and in-home preventive screenings to U.S. health plans and to primary care practices, ACOs, and health systems, using its iVision platform, ComplyHub platform, and proprietary portable fundus camera.
- Ownership category
- akta.pro rank
Retina Labs industry classification
Industry- Product category
- Teleophthalmology and Preventive Health Screening Software
- NAICS
- Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
- akta.pro secondary industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where Retina Labs is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Retina Labs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Health Plan Screening Programs: Provides in-home diabetic eye exams and preventive health screening programs to health plans to help close HEDIS gaps in care and improve Star Ratings. Revenue generated through service delivery contracts with health plan clients.
- Point-of-Care Teleretinal Screening: Enables primary care practices, ACOs, and health systems to offer diabetic eye exams, driving reimbursement revenue through routine screening integration into care delivery workflows.
- Direct-to-Member At-Home Lab Test Kits: Custom branded at-home lab test kits for HbA1c, KED, and Colorectal Cancer delivered directly to health plan members. Includes fulfillment, reminders, member support, test result communications and critical value outreach.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Retina Labs product offering
Product offeringCore offering
Retina Labs delivers cloud-based teleophthalmology services for diabetic eye disease screening through its iVision and ComplyHub platforms, combining proprietary retinal imaging technology, clinical interpretation, and workflow software. The company sells point-of-care teleretinal screening solutions to primary care practices, ACOs, and health systems, and delivers in-home diabetic eye exams and preventive health screenings (HbA1c, KED, colorectal, bone density, blood pressure) on behalf of health plans. Direct-to-member at-home lab test kits are also provided as a co-branded offering to health plan members.
Differentiator
Problem solved
Functional benefit
Brands
- iVision: Industry-leading teleophthalmology and virtual care platform for diabetic retinopathy screening
- ComplyHub
- RetinaLabsForMe
Products and services
- Point-of-Care Teleretinal Diabetic Eye Exam Screening End-to-end teleretinal diabetic eye exam screening solution for primary care practices, ACOs, and health systems. Includes a state-of-the-art retinal camera, cloud-based teleophthalmology platform, retinal image assessment, and remote interpretation to screen patients for diabetic retinopathy during routine care visits.
- In-Home Diabetic Eye Exams & Preventive Health Screenings In-home preventive screening program for health plan members including diabetic eye exams, bone density scans, blood pressure monitoring, and at-home lab test kits designed to drive HEDIS gap closure and improve Star Ratings. Delivered by mobile field technicians using a proprietary portable non-mydriatic fundus camera.
- Direct-to-Member At-Home Lab Test Kits Fully customizable co-branded at-home lab test kits for HbA1c, KED (kidney health), and Colorectal Cancer delivered directly to health plan members. Includes fulfillment, reminders, member support, test result communications, and critical value outreach.
- Teleconsultation Platform Telemedicine-based e-consultation platform for eye health enabling virtual care consultations between primary care providers, specialists, and patients.
Quantifiable outcome
- Less than 50% documented screening compliance rates in the United States - Retina Labs helps address this gap
- +3 more outcomes
Companies that use Retina Labs
Customer profileNamed customers9 records
Segments2 records
Ideal customer profiles2 records
Retina Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature4 records
Retina Labs partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- Wellpoint West VirginiacoreRetina Labs partnered with Wellpoint West Virginia to provide in-home and community-based preventive screenings for Medicaid members, targeting the high diabetes rate in West Virginia. The program aims to improve screening participation and health outcomes through dual care delivery methods including in-home visits and health fairs, increasing access in rural areas. Wellpoint serves more than 150,000 Medicaid and CHIP beneficiaries.
- Sentara Health PlanscoreSentara Health partnered with Retina Labs to deliver in-home preventive health care to members through diabetic eye exams, HbA1c, kidney health assessments, colon cancer testing, and bone mineral density scans. Since launch, Sentara improved quality scores by closing over 10,000 HEDIS gaps while increasing member satisfaction and loyalty.
- The Health Plan of West VirginiacoreLaunched in-home diabetic eye exam and preventive health screening program. Succeeded in closing over 1,800 gaps in care and increasing 2022 STAR ratings.
- VIVA MEDICAREcoreExpanded in-home preventive care services to Alabama through new partnership with VIVA MEDICARE, helping improve access to care for their members using in-home preventive screenings and at-home lab test kits to close more critical HEDIS measures.
- Access Family HealthcoreFederally Qualified Health Centre (FQHC) in Mississippi with 5 medical clinics, 7 school-based clinics, and 1 dental clinic implemented Retina Labs teleretinal screening solution to improve compliance rates for diabetic eye exams and help prevent vision loss in patients with diabetes.
- Ontario Telemedicine Network (OTN)coreRetina Labs was selected by OTN as the solution for its provincial Teleophthalmology Program. iVision platform is the backbone of Ontario's provincial teleophthalmology program, improving province-wide access to diabetic retinopathy screening for urban and remote communities.
- Maisonneuve Rosemont HospitalcoreOne of Montreal's largest hospital centres chose iVision platform for diabetic retinopathy screening program to improve access to retinal screenings for urban communities.
- RUIS McGillcoreMcGill Integrated University Health Network (Reseau Universitaire Integre de Sante) chose Retina Labs iVision Solution for its teleophthalmology program to serve remote community patients at risk for diabetic eye disease.
- First Nations of Quebec and LabradorcoreThe First Nations of Quebec and Labrador Health and Social Services Commission partnered with Retina Labs to provide screening for diabetic retinopathy in First Nations communities.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Retina Labs competitors and assessment
Company assessmentDirect peers
- Intelligent Retinal Imaging Systems (IRIS): Direct teleophthalmology competitor providing retinal screening programs to health plans and primary care providers. Closest comparable in business model, target customer (payers), and end-to-end screening workflow.
- Digital Diagnostics: Develops IDx-DR, the first FDA-cleared autonomous AI for diabetic retinopathy detection. Competes for the same health plan and primary care screening budgets, though via AI interpretation rather than human readers.
Emerging players
- AEYE Health: AI-based diabetic retinopathy screening platform targeting primary care and health systems. Competes for the same HEDIS-driven screening programs but with a software-only, camera-agnostic model.
- Eyenuk: Provides EyeArt, an FDA-cleared AI for autonomous diabetic retinopathy screening used by primary care and endocrinology practices. Comparable as a tech-forward alternative to Retina Labs' human-interpretation workflow.
- Visibly (formerly Opternative): Online vision testing and telehealth platform. Tangentially comparable as a consumer-facing tele-eyecare company, though focused on refraction rather than diabetic retinopathy screening.
Broad incumbents
- Topcon Healthcare: Major ophthalmic device manufacturer offering retinal cameras and screening solutions. Overlaps with Retina Labs in fundus camera hardware and screening workflows, but operates as a broad device vendor rather than a payer-facing screening service.
- Carl Zeiss Meditec: Global ophthalmic equipment leader producing fundus cameras and diagnostic imaging systems used in teleophthalmology programs. Competes indirectly through hardware and integrated screening solutions sold to eye care providers.
- Signify Health (CVS Health): Large in-home health assessment provider for Medicare Advantage plans; Retina Labs' Call Center & Member Engagement Manager previously held senior roles here. Overlaps in the in-home preventive screening value proposition for payers.
- Heidelberg Engineering: Manufacturer of advanced ophthalmic imaging systems (SPECTRALIS) used in retinal diagnostics. Adjacent as an imaging hardware peer feeding teleophthalmology programs.
- Optos (Nikon): Specialist in ultra-widefield retinal imaging used in diabetic retinopathy screening. Comparable as a retinal imaging technology supplier to clinics and screening programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Retina Labs social profiles
Digital presenceRetina Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Retina Labs leadership team
Management profileNumber of profiles
Profiles7 records
Retina Labs funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Retina Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Retina Labs
What does Retina Labs do?
Retina Labs delivers cloud-based teleophthalmology services for diabetic eye disease screening through its iVision and ComplyHub platforms, combining proprietary retinal imaging technology, clinical interpretation, and workflow software. The company sells point-of-care teleretinal screening solutions to primary care practices, ACOs, and health systems, and delivers in-home diabetic eye exams and preventive health screenings (HbA1c, KED, colorectal, bone density, blood pressure) on behalf of health plans. Direct-to-member at-home lab test kits are also provided as a co-branded offering to health plan members.
Is Retina Labs a public or private company?
Retina Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was Retina Labs founded?
Retina Labs was founded in 2009. It employs 1 to 10 people.
Where is Retina Labs based?
Retina Labs is headquartered in Montréal, Canada, in the North America region.
How does Retina Labs make money?
Three revenue lines are on record. Health Plan Screening Programs are the primary driver. The others are point-of-Care Teleretinal Screening and direct-to-Member At-Home Lab Test Kits.
Who are Retina Labs's main competitors?
Direct peers on record are Intelligent Retinal Imaging Systems (IRIS) and Digital Diagnostics. Emerging players are AEYE Health, Eyenuk and Visibly (formerly Opternative). Broad incumbents are Topcon Healthcare, Carl Zeiss Meditec, Signify Health (CVS Health), Heidelberg Engineering and Optos (Nikon).
Does Retina Labs have an API?
No public API is recorded for Retina Labs.
What industry is Retina Labs in?
Retina Labs's product category is Teleophthalmology and Preventive Health Screening Software. Its primary akta.pro industry code is HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers, with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 62151 and its SIC code is 8071.